| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
NOX4, or NADPH oxidase 4, serves as a critical enzyme in cellular redox signaling, generating reactive oxygen species that influence processes ranging from cell differentiation to fibrosis and vascular function. Originally identified in kidney tissue where it earned the designation "kidney oxidase-1," NOX4 has since emerged as a significant player in cardiovascular disease research, diabetic nephropathy studies, and cancer biology, making reliable detection tools essential for investigators working across these fields.
This recombinant monoclonal antibody, clone 7F3, offers the consistency that demanding research protocols require. Because the antibody sequence is defined and produced recombinantly in rabbit host cells, you can expect reproducible performance across experiments and between lots, eliminating the variability that can complicate long-term studies or multi-site collaborations.
Validation data demonstrates robust performance across multiple applications. Western blot analysis detects a clean band at the predicted 67 kDa molecular weight in both SH-SY5Y neuroblastoma and MCF-7 breast cancer cell lysates, confirming specificity in human samples. For tissue-based studies, immunohistochemistry staining has been validated in paraffin-embedded human kidney and ovarian cancer sections using standard citrate buffer antigen retrieval, providing flexibility for researchers examining NOX4 expression in both normal physiology and disease contexts. Flow cytometry validation in HeLa cells further extends the utility of this antibody for single-cell analysis of intracellular NOX4 levels.
Whether you are investigating oxidative stress mechanisms in renal pathology, exploring NOX4's role in tumor microenvironments, or characterizing its contribution to fibrotic disease progression, this antibody provides a reliable foundation for your experimental workflow.
Email: support@cusabio.com
Distributors Worldwide